Skip to the page

Data / Drug companies / Quallent Pharmaceuticals Health LLC

Quallent Pharmaceuticals Health LLC: 164 products in the FDA NDC directory, labeler code 82009

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Quallent Pharmaceuticals Health LLC (labeler code 82009) lists 164 products in the FDA National Drug Code Directory, covering 60 finished drugs by generic name. By type: 164 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on November 2, 2026.

The request: Watch Quallent Pharmaceuticals Health LLC (FDA labeler code 82009): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
82009
Products in commercial distribution
164
Packages
172
Finished drugs by generic name
60
Prescription products
164
Over the counter products
0
Flagged as original packager
145 of 145 products that carry the flag
Started marketing in the last 12 months
17
Products with a marketing end date set
2
Earliest marketing start
June 11, 2014
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)15493.9%
Biologics (BLA)106.1%

Products by type

TypeProductsShare
Prescription drugs164100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet, film coated7143.3%
Tablet4426.8%
Capsule, delayed release116.7%
Capsule106.1%
Kit63.7%
Tablet, extended release42.4%
Tablet, film coated, extended release42.4%
Capsule, delayed release pellets42.4%
Injection, solution42.4%
Capsule, extended release31.8%
Tablet, delayed release21.2%
Tablet, coated10.6%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Dasatinib82009-197Tablet, film coatedGeneric drugs (ANDA)November 2, 2026
Dasatinib82009-196Tablet, film coatedGeneric drugs (ANDA)November 2, 2026
Dasatinib82009-195Tablet, film coatedGeneric drugs (ANDA)November 2, 2026
Dasatinib82009-194Tablet, film coatedGeneric drugs (ANDA)November 2, 2026
Dasatinib82009-193Tablet, film coatedGeneric drugs (ANDA)November 2, 2026
Dasatinib82009-192Tablet, film coatedGeneric drugs (ANDA)November 2, 2026
Eltrombopag82009-201Tablet, film coatedGeneric drugs (ANDA)October 15, 2026
Eltrombopag82009-200Tablet, film coatedGeneric drugs (ANDA)October 15, 2026
Eltrombopag82009-199Tablet, film coatedGeneric drugs (ANDA)October 15, 2026
Eltrombopag82009-198Tablet, film coatedGeneric drugs (ANDA)October 15, 2026
Rosuvastatin82009-191Tablet, film coatedGeneric drugs (ANDA)December 15, 2025
Rosuvastatin82009-190Tablet, film coatedGeneric drugs (ANDA)December 15, 2025
Rosuvastatin82009-189Tablet, film coatedGeneric drugs (ANDA)December 15, 2025
Rosuvastatin82009-188Tablet, film coatedGeneric drugs (ANDA)December 15, 2025
Metformin Hydrochloride82009-181Tablet, extended releaseGeneric drugs (ANDA)December 15, 2025
Metformin Hydrochloride82009-180Tablet, extended releaseGeneric drugs (ANDA)December 15, 2025
Omeprazole82009-183Capsule, delayed releaseGeneric drugs (ANDA)November 15, 2025
Clopidogrel bisulfate82009-182Tablet, film coatedGeneric drugs (ANDA)September 5, 2025
Atorvastatin calcium82009-179Tablet, film coatedGeneric drugs (ANDA)August 1, 2025
Atorvastatin calcium82009-178Tablet, film coatedGeneric drugs (ANDA)August 1, 2025
Atorvastatin calcium82009-177Tablet, film coatedGeneric drugs (ANDA)August 1, 2025
Atorvastatin calcium82009-176Tablet, film coatedGeneric drugs (ANDA)August 1, 2025
Metformin hydrochloride82009-175Tablet, film coatedGeneric drugs (ANDA)July 18, 2025
Metformin hydrochloride82009-174Tablet, film coatedGeneric drugs (ANDA)July 18, 2025
Duloxetine82009-173Capsule, delayed releaseGeneric drugs (ANDA)July 1, 2025

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.